Published in JAMA on February 18, 2004
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med (2015) 4.85
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis (2013) 3.82
Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med (2012) 2.62
Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2009) 2.39
A simple algorithm to predict incident kidney disease. Arch Intern Med (2008) 2.36
Association of age and BMI with kidney function and mortality: a cohort study. Lancet Diabetes Endocrinol (2015) 2.29
Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation (2008) 2.19
Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension (2011) 2.13
Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol (2009) 2.10
Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int (2009) 1.99
High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol (2011) 1.98
A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol (2010) 1.95
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun (2016) 1.94
Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis (2008) 1.92
Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population. Am J Kidney Dis (2011) 1.88
Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ (2009) 1.84
Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis (2008) 1.82
Association of complete recovery from acute kidney injury with incident CKD stage 3 and all-cause mortality. Am J Kidney Dis (2012) 1.81
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ (2013) 1.81
Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care (2014) 1.79
Cardiovascular risk factors in CKD associate with both ESRD and mortality. J Am Soc Nephrol (2013) 1.78
Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem (2013) 1.71
The MYH9/APOL1 region and chronic kidney disease in European-Americans. Hum Mol Genet (2011) 1.71
TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol (2008) 1.71
Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant (2009) 1.71
Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet (2012) 1.68
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet (2011) 1.68
Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol (2013) 1.62
Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet (2011) 1.60
Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57
Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol (2008) 1.56
Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study. J Am Coll Cardiol (2014) 1.56
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis (2013) 1.54
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int (2011) 1.53
Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med (2011) 1.53
Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium. Am J Kidney Dis (2013) 1.52
Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant (2010) 1.46
Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort. Am J Kidney Dis (2015) 1.46
The aging kidney: physiological changes. Adv Chronic Kidney Dis (2010) 1.42
A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol (2013) 1.42
A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet (2007) 1.42
Computed tomography-defined abdominal adiposity is associated with acute kidney injury in critically ill trauma patients*. Crit Care Med (2014) 1.41
Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol (2009) 1.41
Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med (2008) 1.37
Prevalence and awareness of CKD among African Americans: the Jackson Heart Study. Am J Kidney Dis (2009) 1.37
Obesity and change in estimated GFR among older adults. Am J Kidney Dis (2009) 1.37
Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS One (2012) 1.30
Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2011) 1.30
Association of body mass index with outcomes in patients with CKD. J Am Soc Nephrol (2014) 1.30
Evidence-based practice guideline for the treatment of CKD. Clin Exp Nephrol (2009) 1.29
Serum cystatin C and the incidence of type 2 diabetes mellitus. Diabetologia (2011) 1.27
Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2012) 1.27
Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. Clin J Am Soc Nephrol (2011) 1.26
Resistant hypertension--its identification and epidemiology. Nat Rev Nephrol (2012) 1.26
The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci (2009) 1.24
Proton pump inhibitors and acute kidney injury: a nested case-control study. BMC Nephrol (2013) 1.23
High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health (2009) 1.21
Sugary soda consumption and albuminuria: results from the National Health and Nutrition Examination Survey, 1999-2004. PLoS One (2008) 1.20
Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant (2009) 1.17
Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant (2011) 1.14
Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol (2010) 1.14
Trends in diabetes, high cholesterol, and hypertension in chronic kidney disease among U.S. adults: 1988-1994 to 1999-2004. Diabetes Care (2008) 1.14
Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet (2012) 1.14
Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2009) 1.13
Predictors of incident albuminuria in the Framingham Offspring cohort. Am J Kidney Dis (2010) 1.13
Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study. Clin J Am Soc Nephrol (2014) 1.10
Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clin Proc (2008) 1.09
Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol (2009) 1.09
Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes. J Am Soc Nephrol (2013) 1.08
Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol (2011) 1.08
Association between younger age when first overweight and increased risk for CKD. J Am Soc Nephrol (2013) 1.08
Aldosterone and glomerular podocyte injury. Clin Exp Nephrol (2008) 1.07
Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol (2012) 1.07
Elevated galectin-3 precedes the development of CKD. J Am Soc Nephrol (2013) 1.06
Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant (2012) 1.06
Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis. J Am Soc Nephrol (2014) 1.06
Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women. Clin J Am Soc Nephrol (2011) 1.05
Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study. J Am Soc Hypertens (2010) 1.04
Associations of sugar and artificially sweetened soda with albuminuria and kidney function decline in women. Clin J Am Soc Nephrol (2010) 1.04
Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study. Am J Nephrol (2011) 1.03
Relations of measures of endothelial function and kidney disease: the Framingham Heart Study. Am J Kidney Dis (2008) 1.03
Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Kidney Dis (2013) 1.02
The regenerative potential of parietal epithelial cells in adult mice. J Am Soc Nephrol (2014) 1.02
Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One (2012) 1.01
Body mass index and early kidney function decline in young adults: a longitudinal analysis of the CARDIA (Coronary Artery Risk Development in Young Adults) study. Am J Kidney Dis (2013) 1.00
Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol (2008) 1.00
Changes in body weight predict CKD in healthy men. J Am Soc Nephrol (2008) 0.99
Obesity in CKD--what should nephrologists know? J Am Soc Nephrol (2013) 0.98
Serum metabolomic profiling and incident CKD among African Americans. Clin J Am Soc Nephrol (2014) 0.96
Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study). Am J Cardiol (2008) 0.96
Performance of a genetic risk score for CKD stage 3 in the general population. Am J Kidney Dis (2011) 0.96
Epidemiology of chronic kidney disease in heart failure. Heart Fail Clin (2008) 0.95
Development and reproducibility of a computed tomography-based measurement of renal sinus fat. BMC Nephrol (2011) 0.95
Interaction of aging and chronic kidney disease. Semin Nephrol (2009) 0.95
Kidney function decline and physical function in women. Nephrol Dial Transplant (2008) 0.95
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens (2007) 0.95
Obesity, metabolic health, and the risk of end-stage renal disease. Kidney Int (2014) 0.95
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation (2003) 7.40
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med (2004) 7.12
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA (2002) 6.84
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet (2006) 6.39
Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21
Aortic stiffness, blood pressure progression, and incident hypertension. JAMA (2012) 6.01
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation (2006) 5.97
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA (2004) 5.34
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab (2006) 5.33
Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA (2009) 5.22
Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00
Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med (2004) 4.92
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Trends in cardiovascular complications of diabetes. JAMA (2004) 4.74
Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation (2004) 4.73
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation (2008) 4.69
Incidence and prognosis of syncope. N Engl J Med (2002) 4.69
Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA (2005) 4.64
Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA (2004) 4.63
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61
Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension (2004) 4.56
Impact of obesity on plasma natriuretic peptide levels. Circulation (2004) 4.46
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation (2003) 4.43
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation (2005) 4.08
Genomewide linkage analysis of body mass index across 28 years of the Framingham Heart Study. Am J Hum Genet (2002) 4.07